Month: June 2022

WEST PALM BEACH, Fla., June 28, 2022 (GLOBE NEWSWIRE) — PHH Mortgage (“PHH” or the “Company”), a subsidiary of Ocwen Financial Corporation (NYSE: OCN) and a leading non-bank mortgage servicer and originator, announced today that it has entered into an agreement with Federal Home Loan Bank of Indianapolis (“FHLBank Indianapolis”) to purchase mortgage servicing rights (“MSRs”) through its Mortgage Purchase Program (“MPP”). FHLBank Indianapolis has more than 300 depository members and 100 participating financial institutions that originate about $2 billion annually who sell loans into MPP to replenish their capital and minimize portfolio risk. PHH has partnered with FHLBank Indianapolis as both a buyer of MSRs and a strategic partner to provide subservicing solutions to members within the FHLBank Indianapolis footprint. Earlier this...

Belships has entered into agreements for the acquisition of two modern Ultramax bulk carriers built at Japanese shipyards in 2015 and 2017. Belships will pay a total of USD 15.5m as downpayment upon delivery of the vessels. The vessels are currently financed through time charter lease agreements with purchase options significantly below current market levels. Belships has the intention of declaring purchase options for both vessels during the next few months and re-finance the vessels under available bank financing which is expected to cover the amounts for the purchase options. The agreements are conditional upon certain steps to be completed by the parties involved. Delivery of the vessels is expected within July 2022. “These agreements are immediately accretive for Belships’ shareholders and displays our ability to source transactions...

June 28, 2022Announcement no. 12 BioPorto Achieves Targeted Enrollment in Clinical Study Supporting FDA De Novo Submission for The NGAL Test in the U.S. COPENHAGEN, DENMARK and BOSTON, MA, USA, June 28, 2022, (GLOBE NEWSWIRE) — BioPorto A/S (BioPorto) (CPH:BIOPOR) today announced its achievement of targeted subject enrollment for the third part of a 3-part clinical study to support a U.S. Food and Drug Administration (FDA) De Novo submission for use of The NGAL Test in identifying patients under the age of 22 at risk for Acute Kidney Injury (AKI). “We are very pleased to have reached the study’s planned enrollment of 600 patients by the end of Q2, as previously guided,” said Dr. Christopher Bird, BioPorto’s Chief Medical Officer. “We are now reviewing the clinical data to confirm that no additional data is required, after which...

Not for distribution to U.S. news services or for dissemination in the United States CALGARY, Alberta, June 28, 2022 (GLOBE NEWSWIRE) — Helium Evolution Incorporated (TSXV:HEVI) (“HEVI” or the “Company“), a Canadian-based helium exploration and production company focused on developing assets in southern Saskatchewan, is pleased to announce that our first helium well, HEI 06-12-006-05W3M (“HEI-1”), was spud on June 25, 2022 at the Company’s 100% owned and operated McCord property in southern Saskatchewan, described in more detail below. In addition, further to our news release dated June 9, 2022, the Company has closed our non–brokered, brokered and strategic investor private placements raising aggregate gross proceeds of $6,918,200 through the issuance of 17,295,500 total units (“Units”) at $0.40 per Unit. First...